SCHEMBL16877013

SCHEMBL16877013

ON1CCc2c1ccc1ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.41
ALDH1A1 P00352 7/20 0.41
MAPT P10636 6/20 0.41
GLA P06280 2/20 0.40
GAA P10253 2/20 0.40
RCE1 Q9Y256 1/20 0.40
HSD17B10 Q99714 4/20 0.39
TSHR P16473 2/20 0.39
CYP2A6 P11509 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 3/20 0.38
HPGD P15428 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
HPRT1 P00492 1/20 0.37
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
HTR1A P08908 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5271364 0.78 KDM4E (0.50) KDM4EALDH1A1MAPTGLAGAA
SCHEMBL16486276 0.76 KDM4E (0.46) KDM4EALDH1A1MAPTGLAGAA
SCHEMBL18323017 0.74 KDM4E (0.38) KDM4EALDH1A1MAPTGLAGAA
SCHEMBL17988794 0.74 KDM4E (0.38) KDM4EALDH1A1MAPTGLAGAA
SCHEMBL12776570 0.73 KDM4E (0.47) KDM4EALDH1A1MAPTGLAGAA
SCHEMBL1440304 0.71 KDM4E (0.39) KDM4EALDH1A1MAPTGLAGAA
SCHEMBL3434449 0.71 KDM4E (0.40) KDM4EALDH1A1MAPTGLAGAA
SCHEMBL1408791 0.70 ALDH1A1 (0.39) KDM4EALDH1A1MAPTGAAHSD17B10
SCHEMBL179057 0.70 KDM4E (0.39) KDM4EALDH1A1MAPTGLAGAA
SCHEMBL179056 0.70 KDM4E (0.36) KDM4EALDH1A1MAPTGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015103438-A2 ONCOLYTIC VIRUS ADJUNCT THERAPY WITH AGENTS THAT INCREASE VIRUS INFECTIVITY GENELUX CORPORATION (US) 2015-07-09 WO disclosed